News

Net profit of Ind-Swift Laboratories declined 93.20% to Rs 15.11 crore in the quarter ended March 2026 as against Rs 222.27 crore during the previous quarter ended March 2025. Sales rose 22.82% to Rs 169.79 crore in the quarter ended March 2026 as against Rs 138.24 crore during the previous quarter ended March 2025.For the full year,net profit declined 83.46% to Rs 41.42 crore in the year ended March 2026 as against Rs 250.48 crore during the previous year ended March 2025. Sales rose 14.17% to Rs 641.29 crore in the year ended March 2026 as against Rs 561.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales169.79138.24 23 641.29561.71 14 OPM %12.11-6.66 -7.03-3.45 - PBDT25.2222.02 15 90.6659.08 53 PBT17.1114.58 17 60.0634.60 74 NP15.11222.27 -93 41.42250.48 -83 Powered by Capital Market - Live News

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Net profit of Ind-Swift Laboratories reported to Rs 9.54 crore in the quarter ended December 2025 as against net loss of Rs 5.49 crore during the previous quarter ended December 2024. Sales rose 17.12% to Rs 150.85 crore in the quarter ended December 2025 as against Rs 128.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales150.85128.80 17 OPM %2.76-5.16 - PBDT31.08-0.04 LP PBT22.24-5.85 LP NP9.54-5.49 LP Powered by Capital Market - Live News

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2026.Powered by Capital Market - Live News

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News